The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PDL BioPharma Inc

Nasdaq: PDLI
Last

(U.S.) $3.31

Today's change+0.01 +0.30%
Updated September 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

PDL BioPharma Inc

Nasdaq: PDLI
Last

(U.S.) $3.31

Today's change+0.01 +0.30%
Updated September 28 4:00 PM EDT. Delayed by at least 15 minutes.

PDL BioPharma Inc up (U.S.)$0.01

PDL BioPharma Inc closed up Wednesday by (U.S.)$0.01 or 0.30% to (U.S.)$3.31. Over the last five days, shares have lost 1.49% and are down 6.50% for the last year to date. This security has underperformed the S&P 500 by 49.58% during the last year.

Key company metrics

  • Open(U.S.) $3.31
  • Previous close(U.S.) $3.30
  • High(U.S.) $3.33
  • Low(U.S.) $3.25
  • Bid / Ask(U.S.) $3.20 / (U.S.) $3.33
  • YTD % change-6.50%
  • Volume691,696
  • Average volume (10-day)1,549,768
  • Average volume (1-month)1,536,068
  • Average volume (3-month)1,442,284
  • 52-week range(U.S.) $2.58 to (U.S.) $5.35
  • Beta0.74
  • Trailing P/E2.36×
  • P/E 1 year forward6.42×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.20
  • Dividend yield6.04%
  • Trailing EPS(U.S.) $1.40
Updated September 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.19%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue21103178125
Total other revenue--------
Total revenue21103178125
Gross profit--------
Total cost of revenue--------
Total operating expense1010108
Selling / general / administrative710138
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3---20
Other operating expenses, total--------
Operating income1193168116
Interest income (expense), net non-operating-4-5-5-6
Gain (loss) on sale of assets--------
Other--------
Income before tax789163110
Income after tax45610169
Income tax, total3336241
Net income45610169
Total adjustments to net income--------
Net income before extra. items45610169
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items45610169
Inc. avail. to common incl. extra. items45610169
Diluted net income45610169
Dilution adjustment--------
Diluted weighted average shares164164165164
Diluted EPS excluding extraordinary itemsvalue per share0.030.340.610.42
Dividends per sharevalue per share0.050.050.150.15
Diluted normalized EPSvalue per share0.040.340.600.42